WHITEHAWK THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 84.69% for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2025-11-06
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2025-09-30 was 84.69%.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2021-06-30 was 74.57%, a 0.33% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2021-03-31 was 74.16%, a 10.14% increase year-over-year.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2020-06-30 was 74.82%, a 13.42% increase year-over-year.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2020 was 69.36%, a 6.91% increase from fiscal 2019.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2019 was 64.88%, a 1.68% decline from fiscal 2018.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2018 was 65.99%, a 2.34% decline from fiscal 2017.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2017 was 67.57%, a 10.77% increase from fiscal 2016.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month |
|---|---|---|---|---|
| 2025-09-30 | 84.69% 10-Q · filed 2025-11-06 | |||
| 2021-06-30 | 74.57% 10-Q · filed 2021-08-11 | 74.47% 10-Q · filed 2021-08-11 | ||
| 2021-03-31 | 74.16% 10-Q · filed 2021-05-17 | |||
| 2020-12-31 | 69.36% 10-K · filed 2021-03-11 | |||
| 2020-09-30 | 69.36% 10-Q · filed 2020-11-10 | |||
| 2020-06-30 | 74.82% 10-Q · filed 2021-08-11 | 69.36% 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | 67.33% 10-Q · filed 2021-05-17 | |||
| 2019-12-31 | 64.88% 10-K · filed 2021-03-11 | |||
| 2019-09-30 | 65.83% 10-Q · filed 2020-11-10 | |||
| 2019-06-30 | 65.97% 10-Q · filed 2020-08-12 | 65.83% 10-Q · filed 2020-08-12 | ||
| 2019-03-31 | 65.62% 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | 65.99% 10-K · filed 2020-03-16 | |||
| 2018-09-30 | 65.12% 10-Q · filed 2018-11-07 | 66.04% 10-Q · filed 2018-11-07 | ||
| 2018-06-30 | 66.34% 10-Q · filed 2018-08-14 | 66.34% 10-Q · filed 2018-08-14 | ||
| 2017-12-31 | 67.57% 10-K · filed 2019-03-07 | |||
| 2016-12-31 | 61.00% 10-K · filed 2018-03-15 | |||
| 2016-09-30 | 78.00% 10-Q · filed 2017-11-13 | |||
| 2016-06-30 | 78.00% 10-Q · filed 2017-08-10 | 78.00% 10-Q · filed 2017-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |